Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001085037-07-001770
Filing Date
2007-08-03
Accepted
2007-08-03 17:37:27
Documents
1
Period of Report
2007-08-02

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT primary_doc.html 4  
1 PRIMARY DOCUMENT primary_doc.xml 4 5048
  Complete submission text file 0001085037-07-001770.txt   7050
Mailing Address 2 ELZA STREET JERUSALEM L3 93706
Business Address 2 ELZA STREET JERUSALEM L3 93706 011 972-54-7909058
ORAMED PHARMACEUTICALS INC. (Issuer) CIK: 0001176309 (see all company filings)

EIN.: 980376008 | State of Incorp.: NV | Fiscal Year End: 0831
SIC: 1400 Mining & Quarrying of Nonmetallic Minerals (No Fuels)

Mailing Address 2 ELZA STREET JERUSALEM L3 93706
Business Address 972-54-7909058
KIDRON NADAV (Reporting) CIK: 0001351779 (see all company filings)

Type: 4 | Act: 34 | File No.: 000-50298 | Film No.: 071025071